Enhancing Gastrodin Production in by Metabolic Engineering.

Gastrodin, 4-hydroxybenzyl alcohol-4--β-D-glucopyranoside, has been widely used in the treatment of neurogenic and cardiovascular diseases. Currently, gastrodin biosynthesis is being achieved in model microorganisms. However, the production levels are insufficient for industrial applications.